GlassScriptPhysician profile
Stephen M Franklin
NPI 1134237035
$2,113.91
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2020: $397 · 2022: $21.70 · 2023: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $248.67 | 2023 | Illuccix |
| Amgen INC. | $196.55 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.86 | 2019 | |
| Arbor Pharmaceuticals, INC. | $171.27 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $165.56 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $127.51 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $124.65 | 2019-2020 | |
| Abbott Laboratories | $108.91 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $108.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.14 | 2019 | |
| Pfizer INC. | $86.35 | 2019-2020 | |
| Amarin Pharma, INC. | $79.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $78.96 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $67.27 | 2019 | |
| Lundbeck LLC | $47.74 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $43.32 | 2019-2020 | |
| Vifor Pharma, INC. | $40.96 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $39.25 | 2019-2020 | |
| Boston Scientific Corporation | $31.22 | 2019 | |
| Akcea Therapeutics, INC. | $22.05 | 2019 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Portola Pharmaceuticals, LLC | $14.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.